St. Jude Medical, Inc. has taken the opportunity presented by EuroPCR in Paris this week, to announce the start of … continue reading “St.Jude Medical Kicks Off EnligHTNment Study At EuroPCR”
St Jude
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
With EuroPCR* taking place any day, now seems a good time for companies to be previewing their offerings and debuting … continue reading “St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement”
Independent Analysis Says St.Jude’s Optim-Insulated Defib Leads Show Very Low Insulation Failure Rates
St.Jude Medical Inc has issued a press release, telling us that Population Health Research Institute analysis continues to demonstrate strong safety and reliability of Optim-insulated leads. The data was presented at Heart Rhythm 2013 last week.
CE Mark For St.Jude’s Next-Generation Ellipse and SJM Assura ICD/CRT-Ds
St. Jude Medical, Inc. has announced CE Mark approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.
First Quadripolar CRT Pacemaker Gets CE Mark
St. Jude Medical, Inc. has announced CE Mark approval and European launch of its Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). The device brings quadripolar lead technology to the pacemaker market for the first time.
St. Jude Receives First CE Mark Approval Of Deep Brain Stimulation Systems For Both Primary And Secondary Dystonia
The CE mark approval of St.Jude’s deep brain stimulation devices represents the first by a regulatory agency for the use of deep brain stimulation to manage both primary and secondary dystonia.
NEJM Study Publication Gives St.Jude Amplatzer PFO Boost
Eight-year study confirms PFO closure was superior to medical therapy alone in reducing risk of recurrent stroke in prespecified per-protocol and as-treated cohorts.
New St.Jude Trifecta Aortic Valve Study Highlights Hemodynamics And Ease Of Implantation
Newly published data indicates St. Jude Medical Trifecta Heart Valve closely resembles the hemodynamic performance of a natural, healthy heart valve
St.Jude Launches 3-D Vessel Reconstruction Technology in Japan
Japan is the first market to offer St.Jude’s next-generation FFR and OCT ILUMIEN OPTIS System for planning of stent placement
More Focus On Left Atrial Appendage As St.Jude Announces First Trial Implant Of Amplatzer Plug In AF Patient
This year’s ACC Scientific Sessions have been dominated, at least from a headline perspective, by the Left Atrial Appendage. It seems a number of companies are keen to demonstrate their implants can reduce stroke risk by occluding it. St.Jude is one, with its Amplatzer device.
New St.Jude Study To Explore Effects Of Renal Denervation On The Heart
“Super therapy” renal denervation may favourably impact major cardiac events and a new study hopes to demonstrate to what extent. We’ll be fascinated to see the results and are betting the house on the fact that there is a positive effect.
FDA Class I Recall For St. Jude’s Amplatzer™ TorqVue FX Delivery System
St.Jude’s Amplatzer PFO device has its own dedicated delivery system, called Amplatzer “TorqVue”. It seems there is a problem with the core wire on certain batches, all of which are now subject to an FDA class I recall.
Data Says PFO Closure With Amplatzer Lowered Risk Of Recurrent Stroke
Presentation of neurological data confirms patients in the device group had fewer, smaller strokes that were less likely to originate from blood clots passing through the PFO
European Study Sees First Implant For New Size St.Jude Portico™ Heart Valve
St. Jude Medical, Inc. has announced the first patient implant of its 25 mm Portico™ Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.
St.Jude’s New Study May Expand Indication For Renal Denervation
St.Jude will be hoping that a new study of different degrees of hypertension may expand the indication for its EnligHTN renal denervation technology for hypertension to new patient populations.
CE Mark For St.Jude’s ViewFlex Xtra ICE Catheter
St.Jude didn’t miss the opportunity to tout its news at the recent Boston AF symposium last week. Not the least of its offerings was a newly CE marked cardiac catheter which is claimed to offer a new level of manou…maneu…ma… oh it handles really well, OK?